BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

672 related articles for article (PubMed ID: 31122535)

  • 1. Hyaluronic acid improves pain symptoms more than bladder storage symptoms in women with interstitial cystitis.
    Hung MJ; Tsai CP; Lin YH; Huang WC; Chen GD; Shen PS
    Taiwan J Obstet Gynecol; 2019 May; 58(3):417-422. PubMed ID: 31122535
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of intravesical hyaluronic acid therapy on urodynamic and clinical outcomes among women with interstitial cystitis/bladder pain syndrome.
    Peng YC; Yueh-Hsia Chiu S; Feng M; Liang CC
    Taiwan J Obstet Gynecol; 2020 Nov; 59(6):922-926. PubMed ID: 33218413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in sexual function of women with refractory interstitial cystitis/bladder pain syndrome after intravesical therapy with a hyaluronic acid solution.
    Hung MJ; Su TH; Lin YH; Huang WC; Lin TY; Hsu CS; Chuang FC; Tsai CP; Shen PS; Chen GD
    J Sex Med; 2014 Sep; 11(9):2256-63. PubMed ID: 24636240
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urinary and psychological outcomes in women with interstitial cystitis/bladder pain syndrome following hyaluronic acid treatment.
    Liang CC; Lin YH; Hsieh WC; Huang L
    Taiwan J Obstet Gynecol; 2018 Jun; 57(3):360-363. PubMed ID: 29880165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical comparison of intravesical hyaluronic acid and chondroitin sulfate therapies in the treatment of bladder pain syndrome/interstitial cystitis.
    Gülpınar Ö; Esen B; Kayış A; Gökçe Mİ; Süer E
    Neurourol Urodyn; 2018 Jan; 37(1):257-262. PubMed ID: 28480984
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors associated with treatment outcomes after intravesical hyaluronic acid therapy in women with refractory interstitial cystitis: A prospective, multicenter study.
    Tsai CP; Yang JM; Liang SJ; Lin YH; Huang WC; Lin TY; Hsu CS; Chuang FC; Hung MJ
    J Chin Med Assoc; 2021 Apr; 84(4):418-422. PubMed ID: 33784267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systematic Review and Meta-Analysis of Intravesical Hyaluronic Acid and Hyaluronic Acid/Chondroitin Sulfate Instillation for Interstitial Cystitis/Painful Bladder Syndrome.
    Pyo JS; Cho WJ
    Cell Physiol Biochem; 2016; 39(4):1618-25. PubMed ID: 27627755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Repeated intravesical onabotulinumtoxinA injections are effective in treatment of refractory interstitial cystitis/bladder pain syndrome.
    Kuo HC
    Int J Clin Pract; 2013 May; 67(5):427-34. PubMed ID: 23574103
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized, open-label, multicenter study of the efficacy and safety of intravesical hyaluronic acid and chondroitin sulfate versus dimethyl sulfoxide in women with bladder pain syndrome/interstitial cystitis.
    Cervigni M; Sommariva M; Tenaglia R; Porru D; Ostardo E; Giammò A; Trevisan S; Frangione V; Ciani O; Tarricone R; Pappagallo GL
    Neurourol Urodyn; 2017 Apr; 36(4):1178-1186. PubMed ID: 27654012
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A comparative analysis of intravesical sodium hyaluronate monotherapy and its combination with oral chondroitin sulfate in patietns with bladder pain syndrome/intersticial cystitis].
    Aboyan IA; Aboyan VE; Pavlov SV; Zinkovskaya OV; Pavlov DS
    Urologiia; 2019 Apr; (1):35-39. PubMed ID: 31184015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of instillation treatment with hyaluronic acid in relieving symptoms in patients with BPS/IC and uncomplicated recurrent urinary tract infections - Long-term results of a multicenter study.
    Scarneciu I; Bungau S; Lupu AM; Scarneciu CC; Bratu OG; Martha O; Tit DM; Aleya L; Lupu S
    Eur J Pharm Sci; 2019 Nov; 139():105067. PubMed ID: 31499170
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Randomized, Double-blind, Placebo-controlled Trial of Certolizumab Pegol in Women with Refractory Interstitial Cystitis/Bladder Pain Syndrome.
    Bosch PC
    Eur Urol; 2018 Nov; 74(5):623-630. PubMed ID: 30072210
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravesical hyaluronic acid for interstitial cystitis/painful bladder syndrome: a comparative randomized assessment of different regimens.
    Lai MC; Kuo YC; Kuo HC
    Int J Urol; 2013 Feb; 20(2):203-7. PubMed ID: 22925498
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravesical botulinum toxin a injections do not benefit patients with ulcer type interstitial cystitis.
    Lee CL; Kuo HC
    Pain Physician; 2013; 16(2):109-16. PubMed ID: 23511677
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decrease of urinary nerve growth factor but not brain-derived neurotrophic factor in patients with interstitial cystitis/bladder pain syndrome treated with hyaluronic acid.
    Jiang YH; Liu HT; Kuo HC
    PLoS One; 2014; 9(3):e91609. PubMed ID: 24614892
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcomes of intravesical chondroitin-sulfate and combined hyaluronic-acid/chondroitin-sulfate therapy on female sexual function in bladder pain syndrome.
    Arslan B; Gönültaş S; Gökmen E; Özman O; Avci MA; Özdemir E
    Int Urogynecol J; 2019 Nov; 30(11):1857-1862. PubMed ID: 31254047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Do cystometric findings predict the results of intravesical hyaluronic acid in women with interstitial cystitis?
    Daha LK; Riedl CR; Lazar D; Hohlbrugger G; Pflüger H
    Eur Urol; 2005 Mar; 47(3):393-7; discussion 397. PubMed ID: 15716206
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of intravesical hyaluronic acid and chondroitin sulfate on bladder pain syndrome/interstitial cystitis.
    Porru D; Leva F; Parmigiani A; Barletta D; Choussos D; Gardella B; Daccò MD; Nappi RE; Allegri M; Tinelli C; Bianchi CM; Spinillo A; Rovereto B
    Int Urogynecol J; 2012 Sep; 23(9):1193-9. PubMed ID: 21904840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Prospective, Multicenter, Double-Blind, Randomized Trial of Bladder Instillation of Liposome Formulation OnabotulinumtoxinA for Interstitial Cystitis/Bladder Pain Syndrome.
    Chuang YC; Kuo HC
    J Urol; 2017 Aug; 198(2):376-382. PubMed ID: 28202358
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and Feasibility of Intravesical Instillation of Botulinum Toxin-A in Hydrogel-based Slow-release Delivery System in Patients With Interstitial Cystitis-Bladder Pain Syndrome: A Pilot Study.
    Rappaport YH; Zisman A; Jeshurun-Gutshtat M; Gerassi T; Hakim G; Vinshtok Y; Stav K
    Urology; 2018 Apr; 114():60-65. PubMed ID: 29307733
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.